Selling Digital Health Technology to Medicare Payers
Medicare Advantage Rewards Solutions That Can Work on a Delayed Clock
Medicare Advantage creates an unusual commercial challenge. Health plans may have strong incentives to improve quality, document risk accurately, coordinate complex care, and differentiate benefits. Yet the financial recognition of that work can lag far behind implementation.
A digital health company must operate on two clocks at once. The member’s immediate need and the payer’s multiyear planning and measurement cycle. Winning requires a focused value story, an early entry into the calendar, and evidence that can sustain attention before the full return appears.
Start with the Medicare business model
Medicare Advantage plans receive risk-adjusted payments and compete through benefits, networks, experience, quality, and cost management. The population includes adults over 65 as well as younger people who qualify through disability. Within that broad market, needs and economics vary significantly.
Risk adjustment depends on accurate, clinically supported documentation. Star Ratings connect quality and experience performance to financial and market consequences. Supplemental benefits such as dental, vision, hearing, transportation, and food support can differentiate products and address member needs beyond traditional medical services.
Dual-eligible special needs plans add another layer. Members who qualify for both Medicare and Medicaid often have complex medical and social needs, while plans must coordinate across two programs. Integration creates operating challenges but can also create a strong proving ground for solutions that improve navigation, care coordination, access, and engagement.
A startup should determine which mechanism it affects. “Better senior health” is too broad. Improving one Star measure, supporting a defined risk-documentation workflow, reducing avoidable utilization in a high-risk population, or strengthening a supplemental benefit creates a clearer buyer and budget.
Enter before the bid, not before the launch
Medicare Advantage products are shaped through an annual bid process. Plans make benefit, pricing, network, and vendor decisions well before the coverage year begins. A company that approaches a plan shortly before member launch may be one planning cycle late.
We recommend beginning more than a year in advance, with the June bid milestone as a central planning anchor. The exact internal schedule varies, but the company should map backward from the date when the plan must commit. Contracting, security review, integration, communications, provider readiness, and member outreach all need time.
Star performance introduces a longer delay. Measures are collected and reported on defined timelines, and financial or market effects may appear years after the intervention begins. The sales case therefore needs leading indicators that can be observed earlier: outreach, appointment completion, medication adherence, closed gaps, member experience, documentation quality, or changes in near-term utilization.
A delayed return is not automatically unattractive. It becomes difficult when the proposal fails to show how the plan will know whether it is on course.
Focus on one or two measurable levers
Medicare Advantage organizations manage dozens of quality measures, numerous clinical programs, and multiple operational priorities. A startup that claims to improve the entire portfolio can create confusion about where value will appear and who owns it.
The stronger approach is to select one or two measures or economic levers that match the product’s mechanism. The company should identify the eligible population, baseline performance, expected change, data source, implementation dependency, and financial connection.
For a medication-support product, that might mean adherence in a specific chronic condition. For a home-based service, it may involve post-discharge follow-up or avoidable utilization among a high-risk segment. A navigation platform may focus on care transitions for dual-eligible members.
Focused positioning also improves the pilot. The plan can choose a market or population where need is visible, test the operational model, and determine whether broader deployment is justified. A small first step is useful when it is designed as the first stage of a larger decision.
Translate the return into payer math
Medicare buyers will examine how the solution affects revenue, medical cost, administrative cost, and risk. The company should express value in the payer’s own units.
For utilization, that may mean eligible members, baseline events per thousand, expected event reduction, unit cost, program cost, and net impact. For Stars, it may mean the number of gaps that must close, expected measure movement, weighting, and the plan-level effect of crossing a threshold. For risk adjustment, the business case must remain grounded in accurate clinical care and defensible documentation.
The plan will not simply accept a vendor ROI. It will substitute its own prevalence, utilization, cost, and engagement assumptions. A transparent model makes that process easier and exposes where the parties disagree.
Pricing can align with the uncertainty. A plan may prefer a limited pilot, payment for engaged members, case-based fees, or performance components tied to agreed outcomes. A bonus linked to a quality threshold can be compelling, but only if attribution and measurement are realistic. The administrative cost of tracking a complicated contract should not consume the value it creates.
De-risk implementation before promising scale
National Medicare plans offer large populations but have layered governance, extensive security requirements, and complex operations. Regional plans may allow faster access and closer collaboration, although their resources and market reach are smaller.
A regional partner can provide a meaningful first proof if the market, population, and internal champion fit. The company can learn how members engage, how providers respond, what data are available, and which assumptions survive contact with operations. Evidence from one market will not automatically transfer nationally, but it can reduce uncertainty.
Implementation plans should define eligibility, outreach, provider involvement, data exchange, clinical escalation, reporting, and member support. They should also anticipate the older population’s accessibility needs: telephone options, caregiver involvement, language, hearing or vision limitations, and digital confidence.
The product succeeds only if the operating model reaches the intended members.
Follow aging and benefit trends without chasing them
Medical-cost pressure and the growing number of adults over 80 increase interest in home-based care, care coordination, complex-condition management, and support for caregivers. Chronic condition special needs plans create more targeted benefit structures. Supplemental benefits continue to evolve in response to member needs and regulation.
These trends can create openings, but a company should not reposition around every annual change. The durable strategy is to understand the underlying payer problem: avoidable utilization, fragmented care, poor experience, incomplete documentation, or a quality gap.
Regulatory and benefit details should be monitored continuously. A feature that creates value under one year’s rules may be less relevant after a methodology change. A flexible product and evidence model can adapt while preserving the core mechanism.
Build a multiyear commitment around near-term proof
Some Medicare Advantage returns require several measurement periods. A one-year contract can be too short to observe the intended effect, while a long commitment without checkpoints creates buyer risk.
A better structure connects multiyear intent to staged evidence. The first phase proves implementation and engagement. The next demonstrates intermediate clinical or quality outcomes. Later evaluation measures financial performance and supports expansion. Each stage has a defined decision, data set, and responsibility.
This approach respects both clocks. Members receive support now, while the plan builds confidence toward the delayed financial outcome. The company gains time to mature its evidence without asking the buyer to rely on faith.
Medicare Advantage rewards solutions that fit the bid calendar, target a meaningful lever, survive operational scrutiny, and make progress visible long before the final score arrives.
About the Speakers
Sean Flaherty
Solution Sales Executive at Optum
Sean has more than a decade of experience across Medicare Advantage, payer partnerships, and healthcare commercialization. He previously held leadership roles at Kroger, UnitedHealthcare, and Sunny Rewards and advises early-stage medical device companies on reimbursement, payer engagement, and provider adoption Connect with Sean on LinkedIn.
Demi Radeva, MSc
Founder and Chief Strategist at Akros Advisory
Demi has more than a decade of experience across Medicaid, Medicare, and Commercial health plans, including leadership roles at UnitedHealthcare and Optum. She now advises HealthTech companies on reimbursement, payer strategy, market access, and commercialization. Connect with Demi on LinkedIn.
Comments